DR. DAVID LIBELL M.D.
Prescription History 1972695005
Psychiatry & Neurology - Neurology in Morgantown, WV


Quality Rating: 94.1 out of 100 score

NPI Status: Active since September 28, 2006

Contact Information

1 STADIUM DRIVE
MORGANTOWN, WV
ZIP 26506
Phone: (304) 598-4800
Fax: (304) 293-6963

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DAVID LIBELL M.D., an active Neurology specialist practicing in Morgantown, WV. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 204 documented patient claims. Among these therapy options, the most frequently utilized medication is Carbidopa-Levodopa, which accounts for 34 claims alone.


Amitriptyline Hcl

Generic Formulation: Amitriptyline HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 24
30-Day Fills 30.0
Days Supply 900
WV State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills57.5
Peer Average Days Supply1,703
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $221.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.23

State Avg Cost Per Claim

$21.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters such as serotonin) in the brain.

Carbamazepine Er

Generic Formulation: CarbamazepineSpecialty: Neurology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 348
WV State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills33.7
Peer Average Days Supply982
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,672.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$139.34

State Avg Cost Per Claim

$145.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.

Therapeutic Applications

Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.

Carbidopa-Levodopa

Generic Formulation: Carbidopa/LevodopaSpecialty: Neurology
Provider Metrics Summary
Total Claims 34
30-Day Fills 90.0
Days Supply 2,685
WV State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills88.8
Peer Average Days Supply2,505
Conservative Utilization

This provider writes prescriptions for this formulation 39.3% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $816.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.00

State Avg Cost Per Claim

$35.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting.

Carbidopa-Levodopa Er

Generic Formulation: Carbidopa/LevodopaSpecialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 45.0
Days Supply 1,350
WV State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills60.4
Peer Average Days Supply1,747
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.9% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,386.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$92.44

State Avg Cost Per Claim

$66.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms (such as shakiness, stiffness, difficulty moving). Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement. Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. Carbidopa can also reduce some of levodopa's side effects such as nausea and vomiting.

Gabapentin

Generic Formulation: GabapentinSpecialty: Neurology
Provider Metrics Summary
Total Claims 21
30-Day Fills 47.0
Days Supply 1,410
WV State Average Benchmarks
Peer Average Claims118.0
Peer Average 30-Day Fills153.8
Peer Average Days Supply4,347
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 82.2% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $563.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$26.85

State Avg Cost Per Claim

$18.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Levetiracetam

Generic Formulation: LevetiracetamSpecialty: Neurology
Provider Metrics Summary
Total Claims 16
30-Day Fills 42.0
Days Supply 1,260
WV State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills69.8
Peer Average Days Supply1,964
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 66.7% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $396.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.80

State Avg Cost Per Claim

$35.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Phenobarbital

Generic Formulation: PhenobarbitalSpecialty: Neurology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
WV State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills29.1
Peer Average Days Supply764
Conservative Utilization

This provider writes prescriptions for this formulation 45.8% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $695.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$53.53

State Avg Cost Per Claim

$35.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.

Therapeutic Applications

This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Phenobarbital belongs to a class of drugs known as barbiturate anticonvulsants/hypnotics. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure. This medication is also used for a short time (usually no more than 2 weeks) to help calm you or help you sleep during periods of anxiety. It works by affecting certain parts of the brain to cause calming.

Primidone

Generic Formulation: PrimidoneSpecialty: Neurology
Provider Metrics Summary
Total Claims 24
30-Day Fills 48.5
Days Supply 1,316
WV State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills58.7
Peer Average Days Supply1,713
Conservative Utilization

This provider writes prescriptions for this formulation 29.4% less frequently than the standard regional baseline metric for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $772.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.19

State Avg Cost Per Claim

$23.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.

Therapeutic Applications

This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Primidone belongs to a class of drugs known as barbiturate anticonvulsants. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

Propranolol Hcl Er

Generic Formulation: Propranolol HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 21.0
Days Supply 630
WV State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills37.8
Peer Average Days Supply1,123
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $375.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.03

State Avg Cost Per Claim

$68.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Sumatriptan Succinate

Generic Formulation: Sumatriptan SuccinateSpecialty: Neurology
Provider Metrics Summary
Total Claims 16
30-Day Fills 22.6
Days Supply 431
WV State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills24.2
Peer Average Days Supply586
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $240.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.03

State Avg Cost Per Claim

$24.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.

Therapeutic Applications

Sumatriptan is used to treat migraines and cluster headaches. It helps to relieve pain and other symptoms of migraines/headaches including sensitivity to light or sound, nausea, and vomiting. Prompt treatment allows you to get back to your normal routine and may decrease your need for other pain medications. It does not prevent future migraines/headaches or reduce how often you may get a headache. Sumatriptan belongs to a group of drugs called triptans. It affects a certain natural chemical (serotonin) that constricts blood vessels in the brain. It may also block other pain pathways in the brain.

Zonisamide

Generic Formulation: ZonisamideSpecialty: Neurology
Provider Metrics Summary
Total Claims 14
30-Day Fills 16.0
Days Supply 465
WV State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills48.3
Peer Average Days Supply1,413
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.8% less volume than the regional standard for practitioners inside WV. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $244.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.50

State Avg Cost Per Claim

$28.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.

Therapeutic Applications

Zonisamide is used with other medications to prevent and control seizures (epilepsy). Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. DAVID LIBELL M.D. provides transparency into local medical care patterns within Morgantown, WV.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neurology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.